Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 12 January 2026

Trex (TREX) stock jumps 8% on Trump housing move — what to watch next week

Trex (TREX) stock jumps 8% on Trump housing move — what to watch next week

Trex shares jumped 8.2% to $41.65 Friday after President Trump announced a $200 billion purchase of mortgage-backed securities to lower rates. Housing stocks surged, with Lennar up 8.9% and D.R. Horton rising 7.8%. Wolfe Research and UBS recently upgraded Trex, but investors remain wary about whether policy changes will boost housing demand. The December CPI report is due Tuesday.
12 January 2026
··
Hawaiian Electric stock jumps 8% into the weekend — here’s what matters before HE trades again

Hawaiian Electric stock jumps 8% into the weekend — here’s what matters before HE trades again

Hawaiian Electric Industries shares surged 8.1% Friday, closing at $14.77 after trading between $13.64 and $15.05 on heavy volume. The move followed a weaker U.S. jobs report and falling Treasury yields, which lifted utilities broadly. The Hawaii Supreme Court will hear a key case involving the company and insurers on Jan. 27. Hawaiian Electric recently agreed to a $47.75 million shareholder settlement over wildfire-related claims.
12 January 2026
·
Oklo stock: Meta nuclear deal lifts OKLO — what to watch before Monday’s open

Oklo stock: Meta nuclear deal lifts OKLO — what to watch before Monday’s open

Oklo shares jumped 7.9% Friday after announcing a deal with Meta to supply nuclear power to its Ohio project, with Meta able to prepay for electricity and fund early work. The stock briefly surged 18% before closing at $105.31. Insider filings showed CEO Jacob DeWitte and COO Caroline Cochran sold shares under pre-arranged plans as the price climbed. Financial terms of Meta’s prepayment were not disclosed.
12 January 2026
···
Warby Parker stock (WRBY) in focus after co-CEOs’ share sales hit SEC filings

Warby Parker stock (WRBY) in focus after co-CEOs’ share sales hit SEC filings

Warby Parker co-CEOs David Gilboa and Neil Blumenthal sold shares this week through pre-arranged trading plans, according to late Friday SEC filings. WRBY closed at $28.30, up 0.07% for the day and about 25% above its early 2026 price. The sales come as the company pursues a smart eyewear partnership with Google. Investors await further insider filings and the next earnings announcement.
12 January 2026
·
NIO stock slips to $4.64 — what to watch before Monday’s open and a key U.S. inflation print

NIO stock slips to $4.64 — what to watch before Monday’s open and a key U.S. inflation print

NIO’s U.S.-listed shares fell 1.9% to $4.64 Friday, closing out a week marked by the company’s 1,000,000th vehicle milestone. The stock sits 42% below its October peak as traders await U.S. inflation data next week. NIO delivered a record 48,135 vehicles in December and plans further overseas expansion in 2026. Friday’s trading volume was 38 million shares, below the 50-day average.
12 January 2026
·
Bloom Energy stock rallies after AEP’s $2.65 billion fuel-cell order — what to watch before Monday

Bloom Energy stock rallies after AEP’s $2.65 billion fuel-cell order — what to watch before Monday

Bloom Energy shares jumped 10% to close at $134.07 Friday after American Electric Power announced a $2.65 billion deal for Bloom’s fuel cells in a Wyoming project. The agreement includes a 20-year contract with an unnamed buyer, pending conditions expected to clear by Q2 2026. Traders await more details on the end-customer and delivery timeline as the new week begins.
12 January 2026
···
CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week

CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week

CG Oncology shares surged 29.3% to $54.20 after the company moved up its Phase 3 PIVOT-006 trial timeline, now expecting topline results in early 2026. Trading volume reached 7 million shares. Analysts raised price targets following the update and ahead of the JPMorgan Healthcare Conference. The trial enrolls over 360 bladder cancer patients and measures recurrence-free survival.
12 January 2026
··
TVA’s $3 million UT nuclear endowment puts Knoxville’s reactor talent race on display

TVA’s $3 million UT nuclear endowment puts Knoxville’s reactor talent race on display

The Tennessee Valley Authority has committed $3 million to endow a chair in the University of Tennessee, Knoxville’s nuclear engineering department, officials confirmed Sunday. The endowment aims to attract faculty and support research as TVA pursues small modular reactors at its Clinch River site. UT named Brian Wirth as the first chairholder. TVA’s nuclear plants currently supply about 42% of its power.
12 January 2026
Snap stock slides to $8 as CEO share sale surfaces; CPI, earnings date loom

Snap stock slides to $8 as CEO share sale surfaces; CPI, earnings date loom

Snap Inc. shares fell 2.3% Friday to $8.21, marking a third straight decline and leaving the stock near the bottom of its 52-week range. CEO Evan Spiegel sold over 1.2 million shares on Jan. 5 under a pre-arranged plan, according to a recent filing. The broader Nasdaq rose 0.81% the same day. Investors await Tuesday’s U.S. inflation data and Snap’s next earnings report, expected in early February.
12 January 2026
···
UWM stock jumps nearly 14% into Monday as Trump housing plan puts mortgage lenders in play

UWM stock jumps nearly 14% into Monday as Trump housing plan puts mortgage lenders in play

UWM Holdings shares jumped 13.7% to $5.36 Friday on heavy volume, as investors reacted to news of a $200 billion federal mortgage bond-buying plan. The move comes ahead of Tuesday’s Consumer Price Index report, seen as a key signal for mortgage rates. Rocket Companies shares also rose 9.6%. Some Fed officials and analysts questioned whether bond buying alone will lower rates or boost housing activity.
12 January 2026
·
1 … 379 380 381 382 383 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop